Search
for
Sort by
Research 841–870 of 1000+
- Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes
- MANIFESTAÇÕES CUTÂNEAS CORROBORADAS À INFECÇÃO POR SARS-COV-2
- The utilisation of cardiac risk ratio and non-HDL cholesterol markers to assess cardiovascular risk in type 2 diabetes males with lowered serum DHT
- Correlation between Traditional Chinese Medicine Syndromes and Type 2 Myocardial Infarction in Critically Ill Patients with Pulmonary Disease
- The “Science of Aging, Part 2” Supplement
- Introduction to “Science of Aging, Part 2”
- Evaluating cepharanthine analogues as natural drugs against SARS-CoV-2
- Número Actual: Vol. 2 Núm. 4 (2021) Pág. 1-67
- Host-directed FDA-approved drugs with antiviral activity against SARS-CoV-2 identified by hierarchical <i>in silico/in vitro</i> screening methods
- Computational screening of repurposed drugs and natural products against SARS-Cov-2 main protease (Mpro) as potential COVID-19 therapies
- Side Effects of Sodium Valproate among Children with Epilepsy under 2 Years of Age
- <strong>Ultrasound-Assisted Facile Synthesis and Anticancer Evaluation of Novel N-(2-substituted phenyl-4-oxathiazolidine-3-carbonothioyl) benzamide</strong>
- Peer Review #3 of "Computational drug repositioning based on side-effects mined from social media (v0.2)"
- Clinical Quiz No. 2
- 증례 : 몸통의 다발성 판으로 나타난 Bortezomib에 의한 약물 발진 2예
- Contents Vol. 2, 2016
- 만성 B형 간염 환자에서 Pegylated 인터페론 알파2a 치료 중 발생한 원형 탈모
- Study of therapeutic comparison of tacrolimus 0.1% and minoxidil 2% in alopecia areata
- Mykogene und piläre Faktoren des Haarabbaus durch Dermatomyzeten* (2. Mitteilung)
- 1. 2年間の低負荷レジスタンストレーニングが高齢者の筋機能に及ぼす効果(第134回日本体力医学会関東地方会)
- Studies on a hair growth stimulant,procyanidin B-2
- Review: Special Issue on Hair Restoration; The American Journal of Cosmetic Surgery Vol. 14, No. 2, 1997
- Hypopigmented thin scalp hairs association with iron deficiency: report of 2 cases.
- [A critical review of the results of clinical experimentation with topical minoxidil 2%].
- ISID1077 – Efficacy and safety of ENERGI-F701 solution versus 2% minoxidil solution for female pattern hair loss: a phase II, multi-center, randomized, double-blind, head-to-head, parallel trial
- 1077 Efficacy and safety of ENERGI-F701 solution versus 2% minoxidil solution for female pattern hair loss: a phase II, multi-center, randomized, double-blind, head-to-head, parallel trial
- Immunomorphological features of female patient’s skin with androgenetic alopecia in the treatment of platelet-rich plasma in combination with topical minoxidil 2 % lotion
- A randomized, double-blind controlled clinical study to evaluate the efficacy and safety of minoxidil topical 2% nanosuspension with aqueous base in the treatment of androgenetic alopecia areata
- Comparison of the therapeutic effects of Minoxidil 5% solution alone with Flutamide 2% and Minoxidil 5% mixed solution in patients with androgenetic alopecia referring to dermatology clinic of Isfahan university of medical sciences
- 102 Methylation of CpG islands in promoter of type 2 5-α reductase and implications of finasteride resistance for BPH therapy